Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Hogy Medical Co ( (JP:3593) ) is now available.
Hogy Medical Co., Ltd. disclosed that TCG2509 Co., Ltd., the entity conducting a tender offer for its common shares, has filed another amendment to its Tender Offer Registration Statement with the Kanto Local Finance Bureau. The amendment follows a reduction in the waiting period under Japan’s Foreign Exchange and Foreign Trade Act, allowing earlier acquisition of Hogy Medical’s common stock by the offeror.
TCG2509 has also extended the tender offer period to 45 business days, now scheduled to end on March 2, 2026, which is 10 business days after the latest amendment’s submission date. As a result, various items in the tender offer documentation and related public notices have been revised, and Hogy Medical is disclosing these changes in line with Japan’s Financial Instruments and Exchange Act at the request of the offeror, signaling continued regulatory adjustments around the transaction.
The most recent analyst rating on (JP:3593) stock is a Hold with a Yen6857.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.
More about Hogy Medical Co
Hogy Medical Co., Ltd. is a Japan-based company listed on the Tokyo Stock Exchange Prime Market under securities code 3593. The company operates in the medical sector, with its common stock currently the subject of an ongoing tender offer by TCG2509 Co., Ltd., highlighting its role as a target in Japan’s healthcare-related capital markets.
Average Trading Volume: 170,725
Technical Sentiment Signal: Buy
Current Market Cap: Yen144.2B
See more insights into 3593 stock on TipRanks’ Stock Analysis page.